Progression-free survival by IRC Shown is the Kaplan-Meier curve for... | Download Scientific Diagram
Frontiers | Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes | SpringerLink
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value
Progression-Free-Survival (PFS) Analysis in Solid Tumor Clinical Studies
Survival Analysis in R
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
The validity of progression‐free survival 2 as a surrogate trial end point for overall survival - Woodford - 2022 - Cancer - Wiley Online Library
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia